Drager JM-105 Transcutaneous For Sale

Drager JM-105 Transcutaneous Bilirubinometer

The Drager JM-105 Transcutaneous Bilirubinometer is an advanced, non-invasive diagnostic device designed for accurate and efficient screening of neonatal jaundice. Building upon the proven technology of earlier JM series models, the JM-105 delivers fast, reliable bilirubin measurements without the need for blood sampling, improving both patient comfort and clinical workflow in maternity wards, neonatal units, and NICUs.

Using sophisticated multi-wavelength optical measurement technology, the JM-105 analyzes reflected light from subcutaneous tissue to estimate bilirubin levels with high accuracy and strong correlation to serum bilirubin results. This allows clinicians to identify, monitor, and manage hyperbilirubinemia in newborns quickly and safely.

The JM-105 features an ergonomic handheld design with simple, one-touch operation, enabling consistent bedside testing even in high-volume clinical environments. Measurement results are displayed instantly on a clear digital screen, supporting rapid clinical decision-making and reducing delays in treatment.

Designed for durability and everyday clinical use, the Drager JM-105 supports repeated measurements throughout a newborn’s hospital stay. By reducing invasive blood draws, it helps lower infection risk, minimize laboratory costs, and enhance the overall quality of neonatal care.

Key Features

• Non-Invasive Bilirubin Measurement – Measures bilirubin levels through the skin without blood sampling.

• Advanced Optical Technology – Multi-wavelength light analysis for accurate transcutaneous bilirubin readings.

• High Measurement Accuracy – Strong correlation with serum bilirubin values for reliable clinical screening.

• Fast, Instant Results – Provides immediate bilirubin readings within seconds.

• Handheld and Ergonomic Design – Lightweight device for comfortable one-handed operation.

• One-Touch Operation – Simple, intuitive interface ideal for busy neonatal care environments.

• Clear Digital Display – Easy-to-read screen for quick interpretation of results.

• Neonatal-Specific Design – Optimized for newborns of various gestational ages and skin tones.

• Supports Repeated Measurements – Suitable for continuous monitoring throughout a newborn’s hospital stay.

• Durable Clinical Construction – Built for frequent daily use in hospitals, maternity wards, and NICUs.

Key Benefits – Drager JM-105

• Improved Newborn Comfort – Eliminates painful blood sampling, reducing stress for infants and parents.

• Early and Accurate Jaundice Detection – Enables fast identification and monitoring of neonatal hyperbilirubinemia.

• Immediate Clinical Decision Support – Instant results help clinicians make timely treatment decisions.

• Efficient Clinical Workflow – Bedside, non-invasive testing saves time and reduces laboratory dependency.

• Reduced Infection Risk – Minimizes invasive procedures, lowering the chance of infection.

• Cost-Effective Monitoring – Decreases the need for frequent serum bilirubin tests and lab expenses.

• Easy to Use – Simple one-touch operation requires minimal training for healthcare staff.

• Portable and Flexible – Lightweight handheld design for use across maternity wards and NICUs.

• Consistent, Reliable Readings – High repeatability supports ongoing bilirubin trend monitoring.

• Trusted Drager Quality – Backed by Drager’s reputation for precision and reliability in neonatal care.

Technical Specifications

• Device Type: Transcutaneous bilirubinometer

• Measurement Principle: Multi-wavelength optical reflectance technology

• Measurement Range: Typically 0–25 mg/dL (may vary by region/model calibration)

• Accuracy: High correlation with serum bilirubin (validated clinical performance)

• Measurement Site: Forehead or sternum (standard testing locations)

• Display: Clear digital LCD screen showing bilirubin result and status

• Operation: One-touch measurement for immediate results

• Measurement Time: Seconds per reading (instant display)

• Calibration: Factory-calibrated; periodic service calibration recommended

• Patient Population: Neonates and infants of all gestational ages

• Power Source: Rechargeable battery with AC charger

• Battery Life: Supports multiple measurements per full charge (suitable for clinical shifts)

• Design: Handheld, ergonomic clinical form factor

• Weight: Lightweight for portable use (approximately 200–400 g)

• Durability: Designed for frequent daily clinical use

• Compliance: Meets applicable medical device safety and performance standards

• Intended Use: Screening and monitoring of neonatal jaundice